Plain-language reviews of the research, written by the people who source our catalogue. No wellness copy, no pink-washing, no trend-chasing — just the literature, filtered through the axes that matter for women in midlife.
What falls, and when. The GH curve from 35 to 55, why women feel it first, and where peptide research is trying to restore signal.
A 30% dermal collapse in the first five years after menopause. Why the supplement shelf misses the mechanism, and what copper peptide research is asking instead.
Peptide research runs in pulses. The subscription supplement industry does not. Why Juno cadence is aligned with the literature, not the revenue curve.
Peptide literature reviews, hormone-axis explainers, and early access to new SKUs. No filler.